Study finds cisplatin less effective than standard treatment for...

Courtesy EurekAlert! - Cancer  Mon, 04/21/2008 - 23:00

(University of Texas M. D. Anderson Cancer Center) When administered before chemoradiation, the common anti-cancer drug cisplatin neither improved disease-free survival nor reduced the number of colostomies needed when compared to the standard treatment for patients with anal canal cancer, according to a study published in the April 23 issue of the Journal of the American Medical Association.

Sponsors
Tags:

 

Related items

Daniel Fabricant on B Vitamins
Daniel Fabricant, PhD, and vice president of scientific and regulatory affairs for the Natural Products Association is featured in a Nutra...

Silver is the key to reducing pneumonia associated with breathin...
(Washington University School of Medicine) People have long prized silver as a precious metal. Now, silver-coated endotracheal tubes are giving...

Turned-off cannabinoid receptor turns on colorectal tumor growth
(University of Texas M. D. Anderson Cancer Center) New preclinical research shows that cannabinoid cell surface receptor CB1 plays a...

CMV infections affect more than just patients with compromised i...
(University of Washington) An infection due to a virus called cytomegalovirus, which most commonly affects people with compromised immune systems,...

Once suspect protein found to promote DNA repair, prevent cancer
(University of Texas M. D. Anderson Cancer Center) An abundant chromosomal protein that binds to damaged DNA prevents cancer development by enhancing...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com